Sponsor or institution
Clinical trials and research at Solid Biosciences Inc.
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Solid Biosciences Inc. that are recruiting, at sites in 5 countries (most in United States (4), Canada (3), Italy (1)). By phase: Phase 1 (2), Phase 1/2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 5Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| SGT-212 gene therapy for Friedreich's ataxia | Phase 1 | Los Angeles, California and 2 other locations | Recruiting | Sep 18, 2025 |
| SGT-003 gene therapy for ambulant boys and young men with Duchenne muscular dystrophy (IMPACT DUCHENNE) | Phase 3 | Little Rock, Arkansas and 6 other locations | Recruiting | Sep 8, 2025 |
| SGT-501 gene therapy for RYR2-related CPVT | Phase 1 | Boston, Massachusetts and 4 other locations | Recruiting | Aug 29, 2025 |
| Gene therapy for Duchenne muscular dystrophy | Phase 1/2 | Little Rock, Arkansas and 14 other locations | Recruiting | Nov 18, 2023 |
All recruiting trials (4)
-
SGT-212 gene therapy for Friedreich's ataxia
This phase 1b test will try a gene therapy called SGT-212, given into the dentate nucleus and by IV, to see if it is safe and tolerated in people with Friedreich's ataxia.
-
SGT-003 gene therapy for ambulant boys and young men with Duchenne muscular dystrophy (IMPACT DUCHENNE)
This trial will test whether a single intravenous infusion of SGT-003 can help ambulatory boys and young men with Duchenne muscular dystrophy maintain or improve walking and motor function.
-
SGT-501 gene therapy for RYR2-related CPVT
This will test whether a single intravenous dose of SGT-501 is safe and tolerable for people with RYR2-positive CPVT, including adults and children.
-
Gene therapy for Duchenne muscular dystrophy
This study is testing a new gene therapy called SGT-003 to see if it is safe and effective for children with Duchenne muscular dystrophy.
Quick answers
How many clinical trials run by Solid Biosciences Inc. are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in United States (4 trials), Canada (3 trials), Italy (1 trial), United Kingdom (1 trial), Australia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 1/2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.